phase readout
saveNCT03747120: Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]
ACTIVE_NOT_RECRUITINGupdated 10d ago
community read0 votes
Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: HER2-positive Breast Cancer, Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that